Scholars@Duke

Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline Summary.

Publication ,  Journal Article
Lyman, GH; Bohlke, K; Cohen, L
Published in: J Oncol Pract
August 2018
Published version (DOI) Link to item

Duke Scholars

Gary Herbert Lyman
Author Gary Herbert Lyman Medicine, Medical Oncology

Published In

J Oncol Pract

DOI

10.1200/JOP.18.00283

EISSN

1935-469X

Publication Date

August 2018

Volume

14

Issue

8

Start / End Page

495 / 499

Location

United States

Related Subject Headings

  • Societies, Medical
  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Medical Oncology
  • Humans
  • Female
  • Breast Neoplasms
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., Bohlke, K., & Cohen, L. (2018). Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline Summary. J Oncol Pract, 14(8), 495–499. https://doi.org/10.1200/JOP.18.00283
Lyman, Gary H., Kari Bohlke, and Lorenzo Cohen. “Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline Summary.” J Oncol Pract 14, no. 8 (August 2018): 495–99. https://doi.org/10.1200/JOP.18.00283.
Lyman, Gary H., et al. “Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline Summary.” J Oncol Pract, vol. 14, no. 8, Aug. 2018, pp. 495–99. Pubmed, doi:10.1200/JOP.18.00283.

Published In

J Oncol Pract

DOI

10.1200/JOP.18.00283

EISSN

1935-469X

Publication Date

August 2018

Volume

14

Issue

8

Start / End Page

495 / 499

Location

United States

Related Subject Headings

  • Societies, Medical
  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Medical Oncology
  • Humans
  • Female
  • Breast Neoplasms
  • 1112 Oncology and Carcinogenesis